193 related articles for article (PubMed ID: 2401391)
1. Radiolabelled monoclonal antibodies in tumour diagnosis and therapy.
Kosmas C; Kalofonos HP; Epenetos AA
Dev Biol Stand; 1990; 71():93-102. PubMed ID: 2401391
[TBL] [Abstract][Full Text] [Related]
2. Antibody-guided diagnosis and therapy of malignant lesions.
Kalofonos HP; Stewart S; Epenetos AA
Int J Cancer Suppl; 1988; 2():74-80. PubMed ID: 3162448
[TBL] [Abstract][Full Text] [Related]
3. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
Malamitsi J; Skarlos D; Fotiou S; Papakostas P; Aravantinos G; Vassilarou D; Taylor-Papadimitriou J; Koutoulidis K; Hooker G; Snook D
J Nucl Med; 1988 Dec; 29(12):1910-5. PubMed ID: 3193206
[TBL] [Abstract][Full Text] [Related]
4. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
Kalofonos HP; Kosmas C; Hird V; Snook DE; Epenetos AA
Eur J Cancer; 1994; 30A(12):1842-50. PubMed ID: 7880616
[TBL] [Abstract][Full Text] [Related]
5. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.
Epenetos AA; Britton KE; Mather S; Shepherd J; Granowska M; Taylor-Papadimitriou J; Nimmon CC; Durbin H; Hawkins LR; Malpas JS; Bodmer WF
Lancet; 1982 Nov; 2(8306):999-1005. PubMed ID: 6127540
[TBL] [Abstract][Full Text] [Related]
6. Antibody-guided irradiation of malignant pleural and pericardial effusions.
Pectasides D; Stewart S; Courtenay-Luck N; Rampling R; Munro AJ; Krausz T; Dhokia B; Snook D; Hooker G; Durbin H
Br J Cancer; 1986 Jun; 53(6):727-32. PubMed ID: 3718827
[TBL] [Abstract][Full Text] [Related]
7. Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.
Kalofonos HP; Sackier JM; Hatzistylianou M; Pervez S; Taylor-Papadimitriou J; Waxman JH; Lavender JP; Wood C; Epenetos AA
Br J Cancer; 1989 Jun; 59(6):939-42. PubMed ID: 2736231
[TBL] [Abstract][Full Text] [Related]
8. Antibody-guided irradiation of malignant ascites in ovarian cancer: a new therapeutic method possessing specificity against cancer cells.
Epenetos AA; Hooker G; Krausz T; Snook D; Bodmer WF; Taylor-Papadimitriou J
Obstet Gynecol; 1986 Sep; 68(3 Suppl):71S-74S. PubMed ID: 3737085
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy in patients with ovarian cancer.
Kalofonos HP; Giannakenas C; Kosmas C; Apostolopoulos D; Onienadum A; Petsas T; Dimopoulos D; Epenetos AA; Vassilakos PJ
Acta Oncol; 1999; 38(5):629-34. PubMed ID: 10427953
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
Baldwin RW; Embleton MJ; Pimm MV
Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients.
Athanassiou A; Pectasides D; Pateniotis K; Tzimis L; Natsis P; Lafi A; Arapantoni P; Koutsiouba P; Taylor-Papadimitriou J; Epenetos A
Int J Cancer Suppl; 1988; 3():89-95. PubMed ID: 3209306
[TBL] [Abstract][Full Text] [Related]
12. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody targeting of ovarian carcinoma.
Kosmas C; Kalofonos HP; Hird V; Epenetos AA
Oncology; 1998; 55(5):435-46. PubMed ID: 9732222
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
[TBL] [Abstract][Full Text] [Related]
15. Improved tumour localisation using indium-111 labelled antibodies.
Fairweather DS; Bradwell AR; Dykes PW; Vaughan AT; Watson-James SF; Chandler S
Br Med J (Clin Res Ed); 1983 Jul; 287(6386):167-70. PubMed ID: 6409238
[TBL] [Abstract][Full Text] [Related]
16. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
[TBL] [Abstract][Full Text] [Related]
17. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
18. Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody.
Pimm MV; Fells HF; Perkins AC; Baldwin RW
Nucl Med Commun; 1988 Nov; 9(11):931-41. PubMed ID: 3251178
[TBL] [Abstract][Full Text] [Related]
19. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.
Kalofonos HP; Pawlikowska TR; Hemingway A; Courtenay-Luck N; Dhokia B; Snook D; Sivolapenko GB; Hooker GR; McKenzie CG; Lavender PJ
J Nucl Med; 1989 Oct; 30(10):1636-45. PubMed ID: 2795204
[TBL] [Abstract][Full Text] [Related]
20. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
